New Study Shows Exenatide Improves Blood Sugar Levels as Effectively as Insulin Glargine
Copenhagen, Denmark (ots/PRNewswire) - - Patients Taking Exenatide Lost Weight While Patients Taking Insulin Glargine Gained Weight Eli Lilly and Company (NYSE: LLY) and Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today announced results from a study indicating that exenatide improves blood sugar levels as effectively as insulin glargine (Lantus(R), Sanofi ...